Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
For the treatment of pneumonia due to Pneumocystis carinii.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.